Recent Posts

Jury Awards $1.3 Million In Zometa Jaw Injury Trial After Botching 1st Verdict Form
Posted on 23 Sep 2013 by Tom Moylan

ORLANDO, Fla. — (Mealey’s) A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non... Read More

Jury Awards Plaintiff $285,000 In 5th Fosamax MDL Trial But Finds No Design Defect
Posted on 5 Feb 2013 by Tom Moylan

NEW YORK - (Mealey's) A New York federal jury on Feb. 5 ordered Novartis Pharmaceuticals Corp. to pay $285,000 to a plaintiff for allegedly failing to warn her or her doctor that Fosamax carries a risk of osteonecrosis of the jaw (ONJ) ( In Re: Fosamax... Read More